D.C. Code § 44-109.02

Current through codified legislation effective September 4, 2024
Section 44-109.02 - Pre-admission medication management assessment

Within 30 days prior to admission, the ALR shall consult with the prospective resident's healthcare practitioner regarding:

(1) The prospective resident's current medication profile, including a review of nonprescription drugs;
(2) Possible adverse interactions;
(3) Common expected or unexpected side effects; and
(4) The potential that such medications have to act as chemical restraints.

D.C. Code § 44-109.02

June 24, 2000, D.C. Law 13-127, § 902, 47 DCR 2647.